Close
CDMO Safety Testing 2026
Novotech

Recent Trends & Opportunities in Digital Therapeutics Industry: The Future of Healthcare

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Designing Biotech Financial Models for Series B Success

Building a compelling Series B case in biopharma goes well beyond efficacy data and market size projections. Sophisticated investors are increasingly focused on CMC risk, licensing obligations, and the defensibility of your manufacturing timeline. This article breaks down what the financial model behind a strong Series B actually looks like and what quietly kills deals that should have worked.

CMC Bottleneck in Drug Development and IND Delays

Ask any experienced biopharma program manager what derails an IND filing most often, and the answer is rarely surprising: it is CMC. Not insufficient efficacy data, not toxicology surprises CMC. This article examines why Chemistry, Manufacturing, and Controls continues to be the most underestimated risk in early drug development, and what program leaders can do about it.

The Hidden Cost of Licensing in Biologic Drug Development

Royalties, milestone payments, and license fees are often treated as the cost of doing business in biopharma. But for early-stage biotech companies building toward an IND, these obligations can quietly reshape financial models, complicate investor conversations, and create downstream deal terms that are difficult to unwind. Here is what founders need to know.
- Advertisement -

Digital therapeutics is a branch of digital health that is the amalgamation of innovative technologies, services, and products for healthcare and wellness. Digital therapeutics are used independently or in the combination with medical devices, therapies medications are optimized according to the patient care and health outcomes. Digital therapeutics uses the infrastructure of the internet, apps in mobile devices, machine learning, big data, and artificial intelligence to embrace personalized therapies. There is a huge development in different apps providing healthcare benefits to the patients.

Digital therapeutics are changing the medical services and medication system framework with proof-based innovations to work on tolerant results. Digital therapeutics assists with conveying clinical treatments or therapies straightforwardly to the patients utilizing logical reports, clinically assessed programming used to treat patients, their administration, and utilized for the anticipation of persistent sicknesses or problems. Digital therapeutics items have the very arrangement of principles and guidelines as that of customary restorative items and medicines. Digital therapeutics should follow a portion of the basic beliefs like item security, patient centricity, protection, quality, and progressing clinical preliminaries sway on the item.

There is expansion sought after for the computerized helpful items with ascend in reception and acknowledgment of cell phones and tablets for medical services conveyance framework across the globe. Unexpectedly, there is the absence of mindfulness and accessibility of computerized therapeutics framework in emerging nations. This gives a chance to the players to investigate undiscovered business sectors of emerging nations to acquire critical benefits in the digital therapeutics market.

Recent Trends:

  • Rising awareness with respect to digital health & increasing mental health disorders during covid-19 time
  • Expanding investment in digital therapeutics industry due to huge demand
  • Addition of new innovative, smarter applications for the patients medication & care

Growth Factors:

  • Expansion in government financing on medical services, rising reception of innovation, expansion in accessibility and simple admittance to internet and advanced mobile phones are a portion of the elements crediting for the development of the digital therapeutics market.
  • Also, expansion in digitalization in businesses, expanding the board of mental and constant problems will generally upgrade the development of market during estimate period. To convey savvy treatment by diminishing doctors time help the development of the digital therapeutics market.

Leading Companies in Digital Therapeutics Industry:

  • Noom
  • Livongo Health
  • Omada Health
  • WellDoc
  • Pear Therapeutics
  • Proteus Digital Health
  • Propeller Health& others.

Industry Segmentation of Digital Therapeutics Market:
By Applications:

  1. Preventive
  2. Treatment/Care

Key Findings:

  • In light of utilization, diabetes fragment represented the most noteworthy portion of the overall industry in 2020 and expected to build seriously during figure period. Stoutness portion additionally caught critical offer in 2020.
  • Based on Geography, North America dominated the market in year 2020 and Asia Pacific is expected to propel the market with the highest CAGR during the forecast period.

Recent News in Digital Therapeutics Industry:

  • In June 2021, Epillo Health System dispatched EHR framework for facilities and drug stores and portable application to the patients which gives clinical reports and solutions. It is online INTRx Clinical framework assists with dealing with patients’ wellbeing, lab/diet reports and screens illnesses. It likewise assists with overseeing accounts and arrangements.

Covid-19 Scenario:

  • There has been ascend in mindfulness with respect to wellbeing, aversion of actual visits to centers to diminish plausibility of disease, and expansion in psychological wellness issues raised interest for computerized therapeutics during the Covid-19 pandemic.
  • Digital therapeutics new companies and driving players have been tending to conditions, for example, Type 2 diabetes, enslavement, chemical imbalance, and outer muscle wounds through video interviews, delivering educational recordings and online journals on their sites, and appropriating medical services programs through applications.

Latest stories

Related stories

Designing Biotech Financial Models for Series B Success

Building a compelling Series B case in biopharma goes well beyond efficacy data and market size projections. Sophisticated investors are increasingly focused on CMC risk, licensing obligations, and the defensibility of your manufacturing timeline. This article breaks down what the financial model behind a strong Series B actually looks like and what quietly kills deals that should have worked.

CMC Bottleneck in Drug Development and IND Delays

Ask any experienced biopharma program manager what derails an IND filing most often, and the answer is rarely surprising: it is CMC. Not insufficient efficacy data, not toxicology surprises CMC. This article examines why Chemistry, Manufacturing, and Controls continues to be the most underestimated risk in early drug development, and what program leaders can do about it.

The Hidden Cost of Licensing in Biologic Drug Development

Royalties, milestone payments, and license fees are often treated as the cost of doing business in biopharma. But for early-stage biotech companies building toward an IND, these obligations can quietly reshape financial models, complicate investor conversations, and create downstream deal terms that are difficult to unwind. Here is what founders need to know.

Early Phase Decisions Drive Faster Drug Development

Strategic early-stage planning and rigorous regulatory readiness serve as the foundation for accelerating pharmaceutical timelines and optimizing long-term R&D efficiency.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป